Telomerase reverse transcriptase (672-686)

Telomerase reverse transcriptase

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-410

Synonyms/Alias:Telomerase reverse transcriptase (672-686)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
RPGLLGASVLGLDDI
Areas of Interest
Antigen-presenting Cells; Cancer Research

Telomerase reverse transcriptase (672-686) is a synthetic peptide fragment corresponding to amino acid residues 672 to 686 of the human telomerase reverse transcriptase (hTERT) protein. As a segment derived from the catalytic subunit of telomerase, this peptide is of significant interest in biochemical research focused on telomere biology, cellular aging, and cancer-related pathways. Its sequence represents a functionally relevant region of hTERT, making it a valuable tool for studies investigating protein interactions, post-translational modifications, and immune recognition events associated with telomerase activity. The defined nature of this peptide allows for controlled experimental design in both fundamental and applied research contexts.

Epitope mapping: The 672-686 peptide of hTERT serves as a well-characterized epitope for mapping antibody recognition sites. Researchers use this fragment to assess the specificity and binding affinity of monoclonal and polyclonal antibodies raised against telomerase reverse transcriptase. Such studies are essential for validating antibody reagents used in immunoassays, Western blotting, immunoprecipitation, and immunohistochemistry. By providing a consistent and defined target, the peptide facilitates the identification of antibody-epitope interactions and supports the development of reliable immunological tools.

Immunogenicity studies: The peptide is frequently employed in immunological assays designed to evaluate T-cell responses to telomerase-derived epitopes. Its sequence encompasses a region known to be presented by major histocompatibility complex (MHC) molecules, enabling the study of antigen processing, presentation, and T-cell activation in vitro. These investigations contribute to a deeper understanding of immune surveillance mechanisms related to telomerase expression in various cellular contexts, including cancer and stem cell biology. The use of synthetic peptides such as this one allows for precise control over antigenic stimulation in experimental systems.

Protein-protein interaction analysis: As a representative segment of hTERT, the 672-686 peptide is utilized to probe interactions between telomerase and its regulatory partners. By incorporating the peptide into binding assays, researchers can dissect the molecular determinants of telomerase assembly, recruitment, and regulation. This approach enables the identification of critical residues involved in complex formation, providing insights into the functional architecture of the telomerase holoenzyme. Such studies are instrumental in elucidating the molecular basis of telomerase regulation and its implications for cellular homeostasis.

Post-translational modification research: The defined sequence of the 672-686 region makes it suitable for investigating post-translational modifications, such as phosphorylation or acetylation, that may occur within this segment of hTERT. Synthetic peptides facilitate the study of modification-specific recognition by antibodies or interacting proteins, as well as the enzymatic activities responsible for these modifications. By enabling targeted analysis of modified peptides, researchers can uncover regulatory mechanisms that influence telomerase activity and stability at the molecular level.

Assay development and standardization: The use of this peptide fragment supports the creation of quantitative and qualitative assays for telomerase-related research. It serves as a calibration standard or positive control in enzyme-linked immunosorbent assays (ELISA), mass spectrometry-based analyses, and peptide competition experiments. Incorporating the 672-686 sequence into assay platforms ensures reproducibility and accuracy, aiding in the validation of new analytical methods and the comparison of results across different laboratories. The availability of a synthetic, well-defined peptide enhances the reliability and interpretability of data generated in telomerase research workflows.

Source#
Homo sapiens (human)
Epitope
672-686
Restricting HLA
HLA-DR7
References
Schroers; Cancer Res 2002

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Custom Conjugation ServicePeptide Analysis ServicesPeptide CDMOPeptide Modification ServicesEpitope Mapping ServicesPeptide Synthesis ServicescGMP Peptide ServicePeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers